Understanding how Zbtb42 regulates CD8+ T cells in cancer
Regulation of CD8+T cells by Zbtb42
This study is looking at how a protein called Zbtb42 affects a type of immune cell, CD8+ T cells, that helps fight tumors, and it hopes to find ways to make these cells work better in cancer patients by using new techniques.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ut Southwestern Medical Center NIH-funded |
| Lab location | 1 site (Dallas, United States) |
| Project ID | NIH-10915049 on NIH RePORTER |
What this research studies
This research investigates the role of Zbtb42 in regulating CD8+ T cells, which are crucial for the body's anti-tumor response. The study aims to uncover the mechanisms that lead to the dysfunction of these cells in advanced tumors, focusing on how the Zbtb42/T-bet complex influences their effectiveness. Using advanced techniques like CRISPR-Cas9, researchers will explore how manipulating this complex can restore the function of exhausted T cells, potentially improving cancer therapies. Patients may benefit from insights that could lead to new treatments enhancing the immune response against tumors.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with early-stage tumors who may benefit from enhanced anti-tumor immune responses.
Not a fit: Patients with advanced-stage tumors where the mechanisms of T cell exhaustion are already established may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that enhance the effectiveness of CD8+ T cells in fighting cancer.
How similar studies have performed: Other research has shown promising results in manipulating T cell functions, suggesting that this approach could lead to significant advancements in cancer treatment.
Where this research is happening
Dallas, United States
- Ut Southwestern Medical Center — Dallas, United States (Active)
Researchers
- Principal investigator: Poojary, Venuprasad K — Ut Southwestern Medical Center
- Study coordinator: Poojary, Venuprasad K
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.